title: Tinea and Onychomycosis.
abstract: Onychomycosis and tinea pedis are common fungal infections affecting the nails and feet, respectively. Two newly approved topical agents for onychomycosis are efinaconazole and tavaborole, both of which have demonstrated respectable cure rates in clinical studies. For tinea pedis, naftifine 2% and luliconazole 1% are new agents, both administered for relatively short courses, that may foster greater adherence Semin Cutan Med Surg 35(supp6):S110-S113.
authors.affiliation: Professor of Dermatology Baylor College of Medicine Houston, Texas.
authors.forename: Theodore
authors.initials: T
authors.lastname: Rosen
mesh_terms: D000279:Administration, Cutaneous; D000935:Antifungal Agents / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D014009:Onychomycosis / Q000188:drug therapy*; D012008:Recurrence; D014005:Tinea / Q000188:drug therapy*; D014008:Tinea Pedis / Q000188:drug therapy; D014230:Triazoles / Q000627:therapeutic use
chemical_list: D000935:Antifungal Agents; D007093:Imidazoles; D014230:Triazoles; C431707:efinaconazole; C112528:luliconazole
keywords: Efinaconazole; luliconazole; naftifine; onychomycosis; tavaborole; tinea pedis